CClinicalTrials.gg
Status unknownNCT04980963Updated Jul 28, 2021

Cognitive Support Technology for Postsecondary Students With Autism Spectrum Disorder

An interventional study of Cognitive Support Technology (CST) in Autism Spectrum Disorder, sponsored by Kent State University. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-07-28.

Sponsored by Kent State University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2020, registered Sep 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Sex
All
01

Study summary

This study will fill important knowledge gaps in the availability of best practices that use innovative methods to integrate the cognitive and vocational needs of students with Autism Spectrum Disorder (ASD) who will be transitioning from 2- and 4-year postsecondary education to employment. Best practices exist from the assistive technology (AT) field to help people compensate for cognitive impairments, and from the vocational rehabilitation (VR) field to enhance employment outcomes for individuals with disabilities. However, these practices have not been integrated to provide needed supports and services to improve the employment outcomes of students with ASD. The study's goal is to expand the availability of innovative practices by testing the efficacy of a technology-driven, long-term, and resource-rich individualized support program that merges assistive technology for cognition and vocational rehabilitation practices. The end products will include technology application guidelines, training and procedural manuals, and resource information that rehabilitation professionals and students with ADS can utilize to enhance technology and mentoring proficiency, academic success, self-determination, and long-term career success for students with ASD.

The knowledge to be gained from this research will have a beneficial impact on students with ASD, rehabilitation professionals, higher education personnel, case managers, and employers who work with people with ASD. There is strong potential for the students to develop skills that will help them succeed in learning as well as employment settings. The ultimate benefit of research activities for the target population will be seen in the improved capacity for postsecondary students with ADS to utilize state-of-the-art technology to accommodate disability-related limitations, address career readiness, and to prepare for and obtain employment after graduation.

Because the risks to subjects are no greater than those associated with everyday life and because the study staff will refer students who are in psychological distress or medical emergency situations to appropriate resources in the community, the minimal risks of this study justify the considerable benefits that this study will yield. Not only will the study benefit participating students, it stands to make important contributions to the knowledge bases in the fields of assistive technology and rehabilitation.

02

Conditions studied

03

In context

Autistic Disorder

1,344 studies on the registry are indexed under Autistic Disorder; 334 are open to participants now.

This study's planned enrollment of 90 is above the median of 45 across 1,044 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Kent State University is the lead sponsor of 31 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must be a post-secondary student enrolled in degree programs at two-year and four-year colleges or universities within a 60-mile radius of Kent, Ohio
  • Must have a clinical diagnosis of Autism Spectrum Disorder

Exclusion criteria

Exclusion Criteria:

  • No other exclusion criteria will be applied
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Full Treatment

    Steps of the Intervention Condition. Following an in-person session in which a pretest assessment is completed, each member of the intervention group will participate in three face-to-face sessions with the interventionist at the student's campus or at the interventionist's office to complete the CST component of the intervention. Taking into consideration available psychoeducational assessment data, functional assessments from other agencies, and the participant's self-report regarding the functional difficulties that result from his or her ASD-related cognitive impairments, Scherer's (2012) Matching Person and Technology (MPT) protocol will guide the CST assessment. For purposes of the CST component of this intervention, the technological platform for cognitive accommodations will be an iPad II that is provided to each intervention-group participant at no charge (including wireless access if needed). The interventionist will provide training in the use of the iPad if necessary.

    Behavioral: Cognitive Support Technology (CST)

  • Active comparator
    Abbreviated Treatment

    Steps of the Control Condition. Following an in-person session in which the pretest assessment is completed, each member of the control group will participate in two telephone or Skype sessions with the interventionist to discuss her or his needs for electronic cognitive supports. An abbreviated version of Scherer's (2012) MPT assessment will be administered via telephone or Skype in the first of these virtually-administered sessions. In the second telephone or Skype session, the interventionist will summarize the results of the abbreviated MPT assessment, suggest a variety of cognitive enhancement apps for tablet computers or smart phones that the control group participant can consider.

    Behavioral: Cognitive Support Technology (CST)

Interventions

  • BehavioralCognitive Support Technology (CST)

    Cognitive Support Technology (CST) products and strategies are used to help people with disabilities compensate for or accommodate cognitive limitations (including those related to interpersonal communication and social cognition) that present difficulties for them in the performance of desired social roles, especially education and employment. CSTs may be mainstream everyday technologies such as tablet computers or they may be specialized devices designed for specific goals such as step-by-step instruction in the performance of a particular task (Scherer, 2012).

06

What researchers measure

Primary outcomes

  1. Grade Point Average (GPA)

    Participant GPA

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

Secondary outcomes

  1. Current academic standing

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  2. Post-Secondary Enrollment Status

    % of participants still enrolled in a postsecondary program

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  3. Satisfaction with current living status and transportation access

    Measured using single item 5-point Likert question on questionnaire

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  4. Satisfaction with Social Support

    Measured using single item 5-point Likert question on questionnaire

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  5. Current Employment Status

    Three items on questionnaire including dichotomous employment question (e.g., are you employed?), if yes, number of hours employed and weekly earnings.

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  6. % of Participants Receiving Disability Benefits

    Whether participants receive SSDI and/or SSI benefits or not

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  7. Depression Symptoms

    Measured using Beck Depression Inventory- II (BDI-II)

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  8. Overall Health Status

    Measured using RAND 36-item Health Survey

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  9. Perceived Stress

    Measured using Perceived Stress Scale- 10

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  10. Acceptance of Disability

    Measured using the Acceptance of Disability Scale- Short Form

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  11. Quality of Life (QoL)

    Measured using the Qualify of Life Scale

    Time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)

07

Study locations

1 of 1 sites recruiting
  • Kent State University
    Kent, Ohio 44242-0001, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04980963
Lead sponsor
Kent State University
Collaborators
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Jul 28, 2021
Start date
Mar 1, 2020
Primary completion
Jun 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Jul 28, 2021

Study contacts

Mykal Leslie, PhD
Contact
mleslie8@kent.edu
3306725798
Phillip Rumrill, PhD
Contact
prumrill@kent.edu
3306720600

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion